Présentations

• “New legal regime of non interventional studies” – AFAR – 24 January 2017
• Training on R&D agreements and confidentiality of the personnel of the CNRS – Marseille – 12 May 2016
• “Managing the contractual aspects of the relationship with partners within the framework of medicinal product shortage” - L’Entreprise Médicale – 8 April 2015
• “Consequences in terms of liability in case of medicinal product shortage” – L’Entreprise Médicale – 8 April 2015
• Sharing of responsabilities within the framework of pharmacovigilance”  during a training regarding the “Analysis of complex situations of the French pharmacovigilance referent in an international context” – L’Entreprise Médicale – 9 December 2014
• “Health and e-technology, regulatory characteristics ” - LES France – 15 May 2014
• “Cosmetic Industry, its regulatory characteristics” - LES France – 1st October 2013
• “Animal Health Industry, its regulatory  characteristics” – LES France – 18 April 2013
• “National Measures on Transparency : France” – ERA – Annual Conference on EU Pharma Law – Brussels 12 April 2013
• “Health Claims” – LES France – 31 January 2012
• Highlighting and Contrasting the Regulatory Data Protection Application Processes in Europe – C5’s 8th INTERNATIONAL FREEDOM TO OPERATE FORUM –  Munich, 18 May 2011;
• “Up-date on legal issues regarding pharmaceutical and medical devices companies” – CJD Health group –  19 October 2010;
• Round table on pricing and reimbursement : a national perspective for France – Annual pharmaceutical seminar of Conference Bleue in Brussels – 6 November 2009;
• “Legal aspects of bio banks” – Annual meeting of the EU consortium of Bio banking – October 2009;
• Regularly trainings for CAPI and IEEPI regarding R&D agreements and Licensing.

Articles

• “Improvement regarding the unique clinical trial agreement to increase attractiveness of French sites” – Lexology – Decembre 2015  “(http://www.lexology.com/library/detail.aspx?g=8bcf301f-9111-46a3-a94b-4805f20d656e)
• “Legal framework of shortage in France” – Lexology - April 2015  (http://www.lexology.com/library/detail.aspx?g=b3650bc6-edc4-46f3-86e7-3b3fda984ec0)
• “New requirement of a responsible person for medical device manufacturers” – Lexology  - January 2015 (http://www.lexology.com/library/detail.aspx?g=15be5f9d-4c2e-4429-b538-8d2bfc031591)
• The International Comparative Legal Guide to Pharmaceutical Advertising 2014 – French Chapter; [PDF]
• “Adoption of new EU clinical trial regulation” – Lexology - April 2014 (https://www.lexology.com/library/detail.aspx?g=94dafab1-88de-4d2a-a54e-1758b3e2cd8c)
• “French implementation of the EFPIA Code on disclosure of transfers of value in the light of the French Sunshine Act” – Lexology – March 2014 – (http://www.lexology.com/r.ashx?l=7KW8MA1)
• “Data Health Hosting: how far are we ? – March 2013; [PDF]
• “Possible changes in advertising and compliance regulations in France” – Newsletter August 2011; [PDF]
• “French Data protection topics of interest for the Life Sciences Industry” – Newsletter June 2011; [PDF]
• “Advertising of medicinal products versus freedom of expression of a journalist European Court of Justice Decision dated 2 April 2009 (C-421/07) ‘Frede Damgaard’ – Reed Smith Client Alert – April 2009; [PDF]
•  “Pharmaceutical package” – RS Client Alert – février 2009; [PDF]
• “Data Protection within the framework of the Regulation No.1924/2006 on nutrition and health claims made on foods of 20 December 2006” – Conférence Bleue Newsletter – December 2008;
•  “Product liability case-laws in the pharmaceutical sector: the French Civil Supreme Court held important rulings on the causality issue” – Conférence Bleue Newsletter – 22 May 2008.